Join
Live feed
·
PRReleasevia Quantisnow
Scinai Immunotherapeutics Ltd. logo

Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business

ByQuantisnow·Wall Street's wire, on your screen.
SCNI· Scinai Immunotherapeutics Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCNI (Scinai Immunotherapeutics Ltd.) and more on Quantisnow.